The Effect of Inulin in Irritable Bowel Syndrome
Launched by MARDIN ARTUKLU UNIVERSITY · Sep 20, 2024
Trial Information
Current as of July 01, 2025
Completed
Keywords
ClinConnect Summary
In the treatment of IBS, a multimodel perspective that includes psychological support (cognitive behavioural therapy, stress management techniques, etc.) in addition to lifestyle changes (dietary changes, etc.) may be beneficial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • the individuals were between 19-65 years of age
- • volunteer to participate in the study
- • Individuals diagnosed with IBS by a physician according to Rome IV criteria
- Exclusion Criteria:
- • a history of gastrointestinal surgery (except appendectomy and cholecystectomy)
- • inflammatory bowel disease
- • lactose malabsorption
- • gastroenteritis
- • celiac disease
- • gastric
- • duodenal ulcer
- • metabolic diseases (cardiac, hepatic and renal diseases, diabetes, etc.)
- • history of malignancy
- • pregnancy and lactation
- • use of intestinal motility
- • antidepressant drugs
- • involuntary body weight loss of more than 5 kg in the last 3 months
- • use of dietary fibre supplements in the last 3 months
- • use of antibiotics in the last 3 months
- • use of prebiotic and probiotic supplements in the last 3 months.
About Mardin Artuklu University
Mardin Artuklu University is a distinguished academic institution committed to advancing research and education in various fields, including health sciences. As a clinical trial sponsor, the university leverages its expertise and resources to facilitate innovative research initiatives aimed at improving patient outcomes and enhancing medical knowledge. With a focus on ethical standards and scientific rigor, Mardin Artuklu University fosters collaboration among researchers, healthcare professionals, and industry partners to drive impactful clinical studies that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mardin, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported